Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

MLA

Joan Brunet, et al. “Systemic Pro-Inflammatory Response Identifies Patients with Cancer with Adverse Outcomes from SARS-CoV-2 Infection: The OnCovid Inflammatory Score.” Journal for ImmunoTherapy of Cancer, vol. 9, no. 3, Mar. 2021. EBSCOhost, https://doi.org/10.1136/jitc-2020-002277.

APA

Joan Brunet, Josep Tabernero, Mieke Van Hemelrijck, Salvatore Grisanti, Bruno Vincenzi, Isabel Ruiz-Camps, Juan Aguilar-Company, Daniela Ferrante, Oriol Mirallas, Amanda Jackson, Beth Russell, Ramon Salazar, Aleix Prat, Daniele Generali, Nadia Harbeck, Alberto Zambelli, Carlo Alberto Tondini, David J Pinato, Lorenza Rimassa, … Nikolaos Diamantis. (2021). Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score. Journal for ImmunoTherapy of Cancer, 9(3). https://doi.org/10.1136/jitc-2020-002277

Chicago

Joan Brunet, Josep Tabernero, Mieke Van Hemelrijck, Salvatore Grisanti, Bruno Vincenzi, Isabel Ruiz-Camps, Juan Aguilar-Company, et al. 2021. “Systemic Pro-Inflammatory Response Identifies Patients with Cancer with Adverse Outcomes from SARS-CoV-2 Infection: The OnCovid Inflammatory Score.” Journal for ImmunoTherapy of Cancer 9 (3). doi:10.1136/jitc-2020-002277.